Latest update:17 November 2025 at 7:41 PM IST

Chinese company Lonvi Biosciences claims its new life-extension pill could help humans live up to 150 years, but experts are urging caution as the results are so far limited to mouse studies.

The main ingredient in the pill, Procyanidin C1, is said to have increased the lifespan of mice by 9.4%. (Image generated by artificial intelligence)

In a development that has sparked global curiosity and skepticism, a Shenzhen-based biotechnology company has claimed that humans could one day live up to 150 years. The confirmation, made by China’s Lonvi Biosciences, comes at a time when the average human lifespan is between 65 and 70 years.

The company says it has developed what it describes as a “special longevity pill,” designed to slow aging and prolong life by targeting senescent cells, or so-called “zombie cells,” which are senescent cells that stop dividing but continue to cause chronic inflammation in the body. These cells are widely associated with age-related decline, and scientists around the world are studying ways to neutralize them.

According to Lonevy, the pill’s main ingredient is procyanidin C1 (PCC1), a molecule derived from grape seeds. Laboratory experiments on mice are said to have produced amazing results. People who received the formula recorded a 9.4% increase in overall lifespan, while remaining life expectancy from the first day of treatment increased by more than 64%. The company says such data shows the promise of cell-based interventions in significantly extending lifespan.

Liu Qinghua, the company’s chief technology officer, told the New York Times that living to 150 is “definitely realistic,” adding that significant progress could be seen within a few years.

China’s average life expectancy will reach 79 years in 2024, nearly 5 years above the global standard. With growing public interest, policy attention, and increased private investment in longevity research, scientists believe the number may rise even higher.

Jan Yu, co-founder of Shanghai-based longevity startup Time Pie, pointed to the cultural shift underway. “Before, no one in China talked about living longer; this was something that only wealthy Americans explored. Now, many Chinese are investing in longevity,” he said.

Despite the optimism, many experts caution that such claims are still preliminary. While studies in mice are encouraging, the scientific community said extensive human trials were necessary before conclusions about safety or effectiveness could be drawn.

Read more